HomeInsightsPE

Biocon Ltd PE Ratio

Biocon Ltd PE Ratio

stocks purchased

₹ 8.6 Cr

Volume transacted

stocks purchased

273.5 K

stocks traded

Last Updated time: 05 Nov 9.00 AM

Image

Biocon Ltd

NSE: BIOCON

PE

27.2

Last updated on: Nov 05, 2024

Key Highlights

  • The P/E Ratio of Biocon Ltd is 27.2 as of 05 Nov 9.00 AM.
  • The P/E Ratio of Biocon Ltd changed from 40.5 on March 2019 to 31 on March 2024 . This represents a CAGR of -4.36% over 6 years. .
  • The Latest Trading Price of Biocon Ltd is ₹ 315.65 as of 05 Nov 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Biocon Ltd

No data available

Company Fundamentals for Biocon Ltd

No data available

Image

Biocon Ltd

NSE: BIOCON

PRICE

315.65

4.65 (1.50%)

stock direction

Last updated on: Nov 05 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Biocon Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
05 Nov 2024315.65
04 Nov 2024311
01 Nov 2024317.9
31 Oct 2024316.15
30 Oct 2024320.8
29 Oct 2024326.85
28 Oct 2024323.3
25 Oct 2024312.55
24 Oct 2024322.25
23 Oct 2024325.3

SWOT Analysis Of Biocon Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Biocon Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Biocon Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Biocon Ltd2737,896
Sun Pharmaceuticals Industries Ltd384,33,992
Divis Laboratories Ltd931,56,498
Cipla Ltd271,27,968
Mankind Pharma Ltd551,09,574
Torrent Pharmaceuticals Ltd621,08,245

Key Valuation Metric of Biocon Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Biocon Ltd

No data available

* All values are in crore

Historical Revenue of Biocon Ltd

No data available

* All values are in crore

Historical EBITDA of Biocon Ltd

No data available

* All values are in crore

Historical Net Profit of Biocon Ltd

No data available

* All values are in crore

Historical Dividend Payout of Biocon Ltd

No data available

* All values are in %

About Biocon Ltd

  • Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company.
  • The Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in the year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw.
  • Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind.
  • In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International.
  • Also in the same year, the company had received US funding for proprietary technologies.

Biocon Ltd News Hub

News

Biocon Ltd rises for third consecutive session

Biocon Ltd gained for a third straight session today. The stock is quoting at Rs 348.6, up...

Read more

2024-08-20 00:00:00

News

Biocon Q1 PAT soars YoY to Rs 660 cr in FY25

Revenue from operations increased marginally YoY to Rs 3,432.9 crore in during the quarter...

Read more

2024-08-09 00:00:00

News

Biocon consolidated net profit rises 550.59% in the June 2024 quarter

Net profit of Biocon rose 550.59% to Rs 659.70 crore in the quarter ended June 2024 as aga...

Read more

2024-08-09 00:00:00

News

Biocon Ltd up for fifth session

Biocon Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 358.2, ...

Read more

2024-08-22 00:00:00

News

Biocon arm gets USFDA nod for chronic heart failure drug

Sacubitril and valsartan combination is used to treat chronic heart failure in adults to h...

Read more

2024-09-02 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Biocon Ltd

What is the current PE Ratio of Biocon Ltd?

The Current PE Ratio of Biocon Ltd is 27.19 as on 5 Nov 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 5 Nov 2024.

What was the PE Ratio of Biocon Ltd last year?

The PE Ratio of Biocon Ltd was 53.6 last year, now the PE ratio is 27.19, showing a year-on-year growth of -49.3%.

What does the PE Ratio of Biocon Ltd indicate about its stock?

The PE Ratio of Biocon Ltd is 27.19. This ratio indicates that investors are willing to pay 27.19 times the earnings per share for each share of Biocon Ltd.

What is the PE Ratio Growth of Biocon Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Biocon Ltd grew by -49.3% whereas, the EPS ratio grew by -102.4.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*